Corrigendum to “3rd ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 3)” [Breast 31 (February 2017) 244–259]

The authors regret to misspell Dr F. Penault-Llorca's family name. The authors would like to apologise for any inconvenience caused. 3rd ESO–ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3)The BreastVol. 31PreviewAdvanced Breast Cancer (ABC) comprises both locally advanced (LABC) and metastatic breast cancer (MBC) [1]. Although treatable, it is remains an incurable disease with a median overall survival of ∼2–3 years and a 5-year survival of only ∼25% [2–4]. Some more recent series seem to indicate an improvement in median overall survival [5,6]. Full-Text PDF